Vertex Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. 

CEO
Reshma Kewalramani
CEOReshma Kewalramani
Employees
5,400
Employees5,400
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1989
Founded1989
Employees
5,400
Employees5,400

VRTX Key Statistics

Market cap
114.88B
Market cap114.88B
Price-Earnings ratio
28.88
Price-Earnings ratio28.88
Dividend yield
Dividend yield
Average volume
1.20M
Average volume1.20M
High today
$446.09
High today$446.09
Low today
$440.35
Low today$440.35
Open price
$442.00
Open price$442.00
Volume
1.38M
Volume1.38M
52 Week high
$448.40
52 Week high$448.40
52 Week low
$320.01
52 Week low$320.01

VRTX News

Yahoo Finance 3d
Is CRISPR Therapeutics Stock a Buy? - Yahoo Finance

CRISPR Therapeutics (NASDAQ: CRSP) is a star in the gene-editing therapy niche. The company made tremendous progress over the past few years, culminating in its...

Is CRISPR Therapeutics Stock a Buy? - Yahoo Finance
Benzinga 4d
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know - Vertex Pharmaceuticals - Benzinga

Loading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Vertex Pharmaceuticals. Looking at options history for Ver...

Vertex Pharmaceuticals's Options Frenzy: What You Need to Know - Vertex Pharmaceuticals - Benzinga
Yahoo Finance 5d
Jennifer Schneider Elected to Vertex Board of Directors - Yahoo Finance

BOSTON, May 15, 2024--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected...

Jennifer Schneider Elected to Vertex Board of Directors - Yahoo Finance

Analyst ratings

61%

of 33 ratings
Buy
60.6%
Hold
30.3%
Sell
9.1%

More VRTX News

Benzinga 5d
Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'

Loading... Loading... On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management said under $30, Pfizer Inc. PFE is a gift. Pfizer i...

Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'
Yahoo Finance 6d
Here's Why Vertex Pharmaceuticals is a Strong Growth Stock - Yahoo Finance

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. While you may have an investing style...

Here's Why Vertex Pharmaceuticals is a Strong Growth Stock - Yahoo Finance
Investor's Business Daily 6d
Vertex Stock

Highly rated Vertex Pharmaceuticals (VRTX) continues to trade near its all-time high. Even better, it's rising again and within a few points of that benchmark....

Vertex Stock
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.